Continuing FDA Barriers to pediatric trial research in fragile X syndrome
Dr. Erickson provides an update on the latest FDA block on NIH funded and NIH vetted single dose medication research in fragile X syndrome.
Next
Dr. Erickson provides an update on the latest FDA block on NIH funded and NIH vetted single dose medication research in fragile X syndrome.